MEDIANA Co.,Ltd
Financials
Valuation Metrics
MEDIANA Co.,Ltd's Market Cap is ₩1687B. At end of 2025 it was ₩1705B. Ranked #922 of 2,436 in KR market (top 38%), #439 of 1,649 on KOSDAQ (top 27%), #29 of 96 in Health Care Equipment & Services (top 30%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 168.69B KRW | KR#922/2,436 Sec#29/96 |
| Revenue | 66.00B KRW | KR#1,642/2,436 Sec#47/96 |
| Net Income | 6.08B KRW | KR#1,064/2,436 Sec#34/96 |
| Total Assets | 153.33B KRW | KR#1,463/2,436 Sec#44/96 |
| Net Assets | 138.19B KRW | KR#1,166/2,436 Sec#31/96 |
| Employees | 174 | KR#1,188/2,436 Sec#36/96 |
| Value | ||
| P/E | 27.74x | KR#1,227/2,436 Sec#39/96 |
| P/B | 1.22x | KR#1,657/2,436 Sec#51/96 |
| PEG | 0.53x | KR#673/2,436 Sec#27/96 |
| P/S | 2.56x | KR#1,950/2,436 Sec#60/96 |
| EV/EBITDA | 23.05x | KR#1,079/2,436 Sec#34/96 |
| FCF Yield | 2.93% | KR#1,007/2,436 Sec#30/96 |
| Profitability | ||
| ROE | 4.40% | KR#1,073/2,436 Sec#36/96 |
| ROA | 3.97% | KR#797/2,436 Sec#33/96 |
| Op. Margin | 9.55% | KR#519/2,436 Sec#29/96 |
| Revenue Growth | 6.99% | KR#1,072/2,436 Sec#51/96 |
| Earnings Growth | 52.13% | KR#556/2,436 Sec#21/96 |
| Financial Health | ||
| Debt Ratio | 10.96% | KR#14/2,436 Sec#1/96 |
| Total Debt | 3.26B KRW | KR#1,849/2,436 Sec#66/96 |
| FCF | 4.94B KRW | KR#907/2,436 Sec#25/96 |
| Cash | 26.64B KRW | KR#1,069/2,436 Sec#20/96 |
| Current Ratio | 8.37x | KR#133/2,436 Sec#12/96 |
| Net Debt/EBITDA | -3.71x | KR#173/2,436 Sec#7/96 |
| Dividend | ||
| Div. Growth | -49.99% | KR—/2,436 Sec—/96 |
| Performance | ||
| 1Y Return | 56.92% | KR#209/2,436 Sec#3/96 |
| 1M Return | -16.71% | KR#2,082/2,436 Sec#80/96 |
| From 52W High | -69.36% | KR#2,112/2,436 Sec#77/96 |
| 1Y MDD | -74.59% | KR#2,130/2,436 Sec#83/96 |
| Trading | ||
| Volume | 77,415 shares | KR#1,086/2,436 Sec#46/96 |
| Foreign Own. | 5.43% | KR#767/2,436 Sec#26/96 |
| Per Share | ||
| EPS | 327 KRW | KR#1,073/2,436 Sec#33/96 |
| BPS | 7,489 KRW | KR#1,122/2,436 Sec#25/96 |
Company Info
Established in 1995 for medical device manufacturing and sales, the company was listed on KOSDAQ in 2014 and is preparing for AI medical business with its parent company, Selvas AI. It primarily produces patient monitoring devices and defibrillators under ODM and its own brand, while expanding into new business areas such as body composition analyzers and PICC catheters. The company secures a stable sales structure through export contracts with global companies and pursues technology platform innovation through participation in medical device exhibitions and R&D investment. Mediana, established in 1995, is headquartered in Wonju City, Gangwon-do.